KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Long-Term Deferred Tax (2020 - 2024)

BioNTech SE's Long-Term Deferred Tax history spans 4 years, with the latest figure at $87.3 million for Q4 2024.

  • For Q4 2024, Long-Term Deferred Tax changed 0.19% year-over-year to $87.3 million; the TTM value through Dec 2024 reached $87.3 million, changed 0.19%, while the annual FY2024 figure was $88.4 million, 0.55% up from the prior year.
  • Long-Term Deferred Tax for Q4 2024 was $87.3 million at BioNTech SE, roughly flat from $87.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $234.2 million in Q4 2022 and bottomed at $87.3 million in Q4 2024.
  • The 4-year median for Long-Term Deferred Tax is $139.8 million (2023), against an average of $150.3 million.
  • The largest annual shift saw Long-Term Deferred Tax plummeted 62.66% in 2023 before it fell 0.19% in 2024.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $192.2 million in 2020, then grew by 21.88% to $234.2 million in 2022, then tumbled by 62.66% to $87.5 million in 2023, then dropped by 0.19% to $87.3 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Long-Term Deferred Tax are $87.3 million (Q4 2024), $87.5 million (Q4 2023), and $234.2 million (Q4 2022).